Inventor
SONG HUIJUAN
CN11 patents
⚠️ This page may combine multiple inventors who share the name “SONG HUIJUAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
NOVARTIS AG
10 patentsUS9777061B2Oct 3, 2017
Treatment of cancer using a CD33 chimeric antigen receptor
NOVARTIS AG85 citations96
US10287354B2May 14, 2019
Regulatable chimeric antigen receptor
NOVARTIS AG29 citations92
US10640569B2May 5, 2020
Human mesothelin chimeric antigen receptors and uses thereof
NOVARTIS AG15 citations83
US10577417B2Mar 3, 2020
Targeting cytotoxic cells with chimeric receptors for adoptive immunotherapy
NOVARTIS AG10 citations82
US12338287B2Jun 24, 2025
Treatment of cancer using a CD33 chimeric antigen receptor
NOVARTIS AG0 citations61
US11578130B2Feb 14, 2023
Regulatable chimeric antigen receptor
NOVARTIS AG1 citations61
US11459390B2Oct 4, 2022
Phosphoglycerate kinase 1 (PGK) promoters and methods of use for expressing chimeric antigen receptor
NOVARTIS AG0 citations61
US10851166B2Dec 1, 2020
Treatment of cancer using a CD33 chimeric antigen receptor
NOVARTIS AG1 citations61
US11999794B2Jun 4, 2024
Human mesothelin chimeric antigen receptors and uses thereof
NOVARTIS AG0 citations60
US11981731B2May 14, 2024
Targeting cytotoxic cells with chimeric receptors for adoptive immunotherapy
NOVARTIS AG0 citations60